verified_user
Standardful
Homechevron_rightStandardschevron_rightISO 14155:2026
Published — Current Edition; Revision Under DevelopmentInternational Standardupdate Standard Updated: Mar 2026fact_check Fact checked: Nov 13, 2026

ISO 14155:2026

Clinical investigation of medical devices for human subjects — Good clinical practice

apartmentPublishing Organization:International Organization for Standardization (ISO)

Standard Introduction

ISO 14155:2026 is the current fourth edition of the international good clinical practice standard for human clinical investigations of medical devices. Published on 23 March 2026, it replaced ISO 14155:2020 and covers investigation design, conduct, recording and reporting used to evaluate clinical performance, effectiveness and safety.

The edition strengthens participant protection, residual and procedure-related risk assessment, data monitoring, clinical events review, adverse-event reporting, estimands, missing-data planning and follow-up. ISO has already registered a fifth-edition work item, but it is only at an early development stage; ISO 14155:2026 remains the published current edition.

clinical_notes

Medical-Device GCP

Sets good clinical practice for designing, conducting, recording and reporting human clinical investigations that evaluate medical-device clinical performance, effectiveness and safety.

health_and_safety

Participant and Evidence Protection

Combines participant rights, safety and well-being with scientifically sound investigation design, reliable data and credible results for regulatory and conformity-assessment use.

update

Fourth-Edition Changes

The 2026 edition strengthens residual-risk assessment, procedure-related risk management, data monitoring, clinical events review, adverse-event reporting, estimands, missing-data planning and follow-up.

list_alt Core Investigation Controls

  • Ethics review and informed consent
  • Clinical investigation plan objectives, design and endpoints
  • Sponsor and principal-investigator responsibilities
  • Device-use and clinical-procedure risk management
  • Data monitoring and clinical events committee decisions
  • Electronic clinical data and record integrity
  • Adverse-event and device-deficiency assessment and reporting
  • Suspension, termination, follow-up and final reporting

Who Needs to Comply?

groups

Medical-device manufacturers and sponsors planning human clinical investigations; principal investigators and investigation sites; contract research organizations; ethics committees; data, statistics and safety teams; and service providers supporting clinical evidence. The standard can be applied as relevant to post-market investigations and Software as a Medical Device. It does not directly apply to in vitro diagnostic devices, although national or regional rules may make selected provisions relevant.

Key Requirements

1

Ethics and Informed Consent

Obtain the required ethics approval and informed consent before investigation procedures, protect subjects' rights and well-being, and account for legally designated representatives and meaningful opportunities to discuss participation where applicable.

2

Investigation Design and Statistical Planning

Define clinically relevant objectives, endpoints, comparators, eligibility criteria, methods and analysis. Address estimands, non-inferiority margins, missing data, equipment calibration and stopping conditions in proportion to the investigation.

3

Risk Management

Distinguish risks from use of the investigational device from risks introduced by clinical procedures outside routine practice, assess residual risks, define controls and connect investigation decisions to ISO 14971 risk management.

4

Oversight Committees

Define whether a data monitoring committee and clinical events committee are needed, document independence and responsibilities, and establish review, adjudication, escalation, suspension or stopping rules.

5

Data and Safety Records

Maintain traceable electronic and paper records, protect confidentiality, control access and changes, document device deficiencies and adverse events, and apply the applicable reduced or full reporting pathways.

6

Sponsor, Investigator and Follow-Up Duties

Document delegated activities without losing accountability, control the investigational device, train users, monitor sites, manage suspension or early termination, provide necessary follow-up and continued care, and issue an accurate clinical investigation report.

Implementation Roadmap

1
Step 1schedule Duration: Planning estimate: 2-4 weeks

Confirm investigation and market scope

Identify the investigational device, intended purpose, development stage, target populations, sites and jurisdictions. Confirm whether the work is pre-market, post-market or SaMD-related, and record applicable law, ethics rules, regulator guidance and conformity-assessment expectations alongside ISO 14155:2026.

2
Step 2schedule Duration: Project estimate: 3-8 weeks

Run a 2020-to-2026 gap review

Compare controlled procedures and templates with the fourth edition. Prioritize eligibility deviations, informed consent, procedure-related risks, residual-risk assessment, data monitoring and clinical events committees, adverse-event pathways, estimands, missing data, implant cards and subject follow-up.

3
Step 3schedule Duration: Project estimate: 6-16 weeks

Design the investigation and oversight

Finalize the clinical investigation plan, statistical analysis approach, risk controls, monitoring strategy, committee charters, event-adjudication rules, suspension criteria, data flows, equipment calibration and sponsor-investigator-service-provider responsibilities.

4
Step 4schedule Duration: Before first enrolment

Approve, train and initiate

Obtain ethics and regulatory approvals, verify informed-consent materials, qualify sites and systems, train investigators and users, control investigational devices, test escalation paths and confirm that essential records can reconstruct decisions and data changes.

5
Step 5schedule Duration: Throughout and after the investigation

Monitor, report and close

Monitor conduct and data quality, assess adverse events and device deficiencies, operate oversight committees, manage amendments or suspension, preserve follow-up and continued-care decisions, reconcile devices and records, analyse results and issue the clinical investigation report.

Compliance Checklist

0 / 16

checklist Applicability and governance

checklist Design, risk and statistics

checklist Participants and conduct

checklist Data, safety and closure

ISO 14155:2020 to 2026 transition focus

Use the official redline or controlled standard text for clause-level work; this table identifies the operational areas that need review.

Review area2026 focusImplementation evidence
Risk managementSeparates device-use and procedure-related risks and strengthens residual-risk assessmentRisk analysis, control decisions and benefit-risk records
OversightStrengthens DMC stopping conditions and adds clinical events committee provisionsCommittee rationale, charters, independence and decisions
StatisticsAdds estimand concepts and clarifies non-inferiority and missing-data planningCIP and statistical analysis plan rationale
Safety reportingClarifies event categories, reduced-reporting situations and suspension processesEvent records, adjudication, notifications and escalation logs
ParticipantsClarifies representatives, discussion opportunities, follow-up and continued careConsent materials, follow-up plans and care records
Device and procedure recordsAdds implant-card, calibration, training and in-silico considerationsDevice accountability, calibration, training and justification records

Common Misconceptions

cancel
Myth

ISO 14155 is the same as ICH E6.

check_circle
Reality

Both address good clinical practice, but ISO 14155 is specific to medical-device investigations. ICH E6 primarily addresses clinical trials intended for medicines-regulatory use.

cancel
Myth

Following the 2020 edition is enough because the new edition is already under revision.

check_circle
Reality

ISO 14155:2020 is withdrawn. The fifth edition is only an early work item, so ISO 14155:2026 is the current published edition.

cancel
Myth

A signed consent form is the complete informed-consent process.

check_circle
Reality

Consent also requires approved information, appropriate discussion, voluntariness, timing and use of a legally designated representative where applicable.

cancel
Myth

Only risks caused directly by the device belong in the investigation plan.

check_circle
Reality

The 2026 edition also emphasizes risks introduced by clinical procedures required by the investigation plan when those procedures are outside routine practice.

Penalties & Enforcement

warning

ISO 14155:2026 is a voluntary International Standard and is not a standalone certification or penal regime. Regulators, ethics committees, notified bodies, contracts or national law may require or recognize its practices. Weak subject protection, investigation conduct or evidence can lead to ethics findings, corrective action, investigation suspension, unusable data, delayed or refused regulatory decisions, and jurisdiction-specific enforcement.

Frequently Asked Questions

What is ISO 14155:2026?

expand_more

ISO 14155:2026 is the fourth edition of the international good clinical practice standard for designing, conducting, recording and reporting human clinical investigations of medical devices. ISO published it on 23 March 2026 and withdrew the 2020 edition.

Is ISO 14155:2026 mandatory?

expand_more

Not by itself. It is a voluntary International Standard, but regulators, ethics committees, notified bodies, contracts or national rules can require or recognize its practices. Organizations must verify the legal and conformity-assessment framework in every investigation market.

Does ISO 14155 apply to post-market clinical investigations?

expand_more

Its principles are intended to be followed as far as relevant to the purpose, design and nature of the post-market investigation. The applicability decision and any mandatory requirements also depend on national or regional rules.

Does ISO 14155 apply to SaMD and IVDs?

expand_more

For Software as a Medical Device, the requirements apply as far as relevant to the clinical investigation and the evidence being generated. The standard does not directly apply to in vitro diagnostic devices, although a jurisdiction can make selected provisions relevant.

What changed from ISO 14155:2020?

expand_more

The fourth edition clarifies eligibility, informed consent, clinical performance, adverse-event reporting and suspension. It strengthens residual and procedure-related risk assessment, data monitoring, clinical events committees, statistical estimands, missing-data planning, implant cards, equipment calibration and follow-up.

Can a company be certified to ISO 14155?

expand_more

ISO 14155 is not an organizational management-system certification standard. Investigation compliance is evaluated through ethics and regulatory oversight, sponsor monitoring, audits, inspections, conformity assessment and review of the clinical evidence.

Is ISO 14155:2026 already being replaced?

expand_more

It remains the published current edition. ISO registered a fifth-edition approved work item on 22 June 2026 at Stage 20.00, which means a revision is under early development; it is not a published replacement.

Official Documentation

View All

Implementation Timeline

flag
2003
First edition of ISO 14155 published
update
2011
Second edition consolidates clinical investigation good-practice requirements
description
Jul 2020
Third edition published
verified
23 Mar 2026
Fourth edition published and ISO 14155:2020 withdrawn
pending_actions
22 Jun 2026
ISO registers a fifth-edition approved work item at Stage 20.00; the 2026 edition remains current

Related Categories